Evidence map›Paper›PMID 28331542›Full record

ArticleBiotechnology for biofuels2017

Expression of a heat-stable NADPH-dependent alcohol dehydrogenase from

Sun-Ki Kim, Joseph Groom, Daehwan Chung, James Elkins, Janet Westpheling

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Effects ofFrontiers in bioengineering and biotechnology · 2022
    Article
  5. Tolerance to Glutaraldehyde inFrontiers in microbiology · 2021
    Article
  6. Article
  7. Firmicutes-enriched ISBiotechnology for biofuels · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sun-Ki KimDepartment of Genetics, University of Georgia, Athens, GA USA.
Joseph GroomDepartment of Genetics, University of Georgia, Athens, GA USA.
Daehwan ChungBiosciences Center, National Renewable Energy Laboratory, Golden, CO USA.
James ElkinsBiosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN USA.
Janet WestphelingDepartment of Genetics, University of Georgia, Athens, GA USA.
University of Georgia · USNational Renewable Energy Laboratory · USOak Ridge National Laboratory · US

Funding

T32 Predoctoral training grant in geneticsT32GM007103 · NIGMS · UNIVERSITY OF GEORGIA (UGA) · PI DYER, KELLY A · 1985 to 2021
$5.9M
NIGMS NIH HHS T32 GM007103
6 · The paper itself

Abstract

backgroundResistance to deconstruction is a major limitation to the use of lignocellulosic biomass as a substrate for the production of fuels and chemicals. Consolidated bioprocessing (CBP), the use of microbes for the simultaneous hydrolysis of lignocellulose into soluble sugars and fermentation of the resulting sugars to products of interest, is a potential solution to this obstacle. The pretreatment of plant biomass, however, releases compounds that are inhibitory to the growth of microbes used for CBP.

resultsHeterologous expression of the

conclusionsToxic compounds present in lignocellulose hydrolysates that inhibit cell growth and product formation are obstacles to the commercialization of fuels and chemicals from biomass. Expression of genes that reduce the effect of these inhibitors, such as furan derivatives, will serve to enable commercial processes using plant biomass for the production of fuels and chemicals.

Indexed as

5-hydroxymethyl-2-furfuralButanol dehydrogenaseClostridium thermocellumConsolidated bioprocessingFurfural

Identifiers

PMID28331542
PMCPMC5353787
OpenAlexW2596206768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.